We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Exploring Analyst Estimates for UiPath (PATH) Q2 Earnings, Beyond Revenue and EPS
Read MoreHide Full Article
In its upcoming report, UiPath (PATH - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $0.15 per share, reflecting no change compared to the same period last year. Revenues are forecasted to be $397.59 million, representing a year-over-year increase of 9.9%.
The current level reflects no revision in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
That said, let's delve into the average estimates of some UiPath metrics that Wall Street analysts commonly model and monitor.
It is projected by analysts that the 'Revenue- Licenses' will reach $114.60 million. The estimate indicates a change of +2.2% from the prior-year quarter.
The consensus among analysts is that 'Revenue- Professional Services and other' will reach $11.86 million. The estimate points to a change of +5.9% from the year-ago quarter.
According to the collective judgment of analysts, 'Revenue- Subscription services' should come in at $271.07 million. The estimate indicates a year-over-year change of +13.7%.
Analysts' assessment points toward 'ARR' reaching $1.93 billion. The estimate is in contrast to the year-ago figure of $1.72 billion.
Based on the collective assessment of analysts, 'Net New ARR' should arrive at $30.50 million. Compared to the present estimate, the company reported $31.00 million in the same quarter last year.
Analysts predict that the 'Dollar based net retention rate' will reach 109.0%. The estimate compares to the year-ago value of 108.0%.
Over the past month, UiPath shares have recorded returns of +42.2% versus the Zacks S&P 500 composite's +3.9% change. Based on its Zacks Rank #3 (Hold), PATH will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
View the Zacks #1 Rank List
Image: Bigstock
Exploring Analyst Estimates for UiPath (PATH) Q2 Earnings, Beyond Revenue and EPS
In its upcoming report, UiPath (PATH - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $0.15 per share, reflecting no change compared to the same period last year. Revenues are forecasted to be $397.59 million, representing a year-over-year increase of 9.9%.
The current level reflects no revision in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
That said, let's delve into the average estimates of some UiPath metrics that Wall Street analysts commonly model and monitor.
It is projected by analysts that the 'Revenue- Licenses' will reach $114.60 million. The estimate indicates a change of +2.2% from the prior-year quarter.
The consensus among analysts is that 'Revenue- Professional Services and other' will reach $11.86 million. The estimate points to a change of +5.9% from the year-ago quarter.
According to the collective judgment of analysts, 'Revenue- Subscription services' should come in at $271.07 million. The estimate indicates a year-over-year change of +13.7%.
Analysts' assessment points toward 'ARR' reaching $1.93 billion. The estimate is in contrast to the year-ago figure of $1.72 billion.
Based on the collective assessment of analysts, 'Net New ARR' should arrive at $30.50 million. Compared to the present estimate, the company reported $31.00 million in the same quarter last year.
Analysts predict that the 'Dollar based net retention rate' will reach 109.0%. The estimate compares to the year-ago value of 108.0%.
View all Key Company Metrics for UiPath here>>>Over the past month, UiPath shares have recorded returns of +42.2% versus the Zacks S&P 500 composite's +3.9% change. Based on its Zacks Rank #3 (Hold), PATH will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .